301 open positions in rare diseases
GenScript
Amgen
BridgeBio Pharma
Aspa Therapeutics
QED Therapeutics
MyOme
Takeda
Ipsen
Zevra Therapeutics
Regeneron
Travere Therapeutics
Forge Biologics